[ad_1]
Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) traded up 3.3% during mid-day trading on Monday . The company traded as high as $1.45 and last traded at $1.50. 1,861,928 shares changed hands during trading, an increase of 371% from the average session volume of 395,698 shares. The stock had previously closed at $1.45.
Separately, Zacks Investment Research cut Corindus Vascular Robotics from a “buy” rating to a “hold” rating in a research report on Tuesday, November 13th.
A number of large investors have recently made changes to their positions in the business. HRT Financial LLC purchased a new stake in Corindus Vascular Robotics in the fourth quarter valued at approximately $44,000. Millennium Management LLC raised its holdings in Corindus Vascular Robotics by 1.0% during the fourth quarter. Millennium Management LLC now owns 7,088,692 shares of the medical equipment provider’s stock worth $5,955,000 after purchasing an additional 68,250 shares in the last quarter. Jane Street Group LLC acquired a new position in Corindus Vascular Robotics during the fourth quarter worth about $36,000. Barclays PLC acquired a new stake in shares of Corindus Vascular Robotics in the fourth quarter valued at approximately $325,000. Finally, Nomura Holdings Inc. grew its position in shares of Corindus Vascular Robotics by 18.6% in the fourth quarter. Nomura Holdings Inc. now owns 1,262,445 shares of the medical equipment provider’s stock valued at $1,077,000 after purchasing an additional 198,111 shares during the last quarter.
COPYRIGHT VIOLATION NOTICE: “Corindus Vascular Robotics (CVRS) Trading Up 3.3%” was published by PressOracle and is the sole property of of PressOracle. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://pressoracle.com/news/2019/03/04/corindus-vascular-robotics-cvrs-trading-up-3-3.html.
Corindus Vascular Robotics Company Profile (NYSEAMERICAN:CVRS)
Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.
Recommended Story: Short Selling Stocks and Day Traders
Receive News & Ratings for Corindus Vascular Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Corindus Vascular Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.
[ad_2]
Source link
Leave A Comment
You must be logged in to post a comment.